Graft-versus-hostreactie (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Graft-versus-hostreactie" in Dutch language version.

refsWebsite

Global rank Dutch rank

5nih.gov

4^th place

12^th place

3doi.org

2^nd place

8^th place

2web.archive.org

1^st place

2worldcat.org

5^th place

28^th place

1ashpublications.org

low place

1nature.com

234^th place

128^th place

1wiley.com

222^nd place

224^th place

ashpublications.org

(en) Broers, Annoek E. C., de Jong, Cornelis N., Bakunina, Katerina, Hazenberg, Mette D., van Marwijk Kooy, Marinus (14 juni 2022). Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial. Gearchiveerd op 1 juni 2023. Blood Advances 6 (11): 3378–3385. ISSN:2473-9529. PMID: 35143644. PMC: PMC9198908. DOI:10.1182/bloodadvances.2021005847.

doi.org

dx.doi.org

(en) Broers, Annoek E. C., de Jong, Cornelis N., Bakunina, Katerina, Hazenberg, Mette D., van Marwijk Kooy, Marinus (14 juni 2022). Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial. Gearchiveerd op 1 juni 2023. Blood Advances 6 (11): 3378–3385. ISSN:2473-9529. PMID: 35143644. PMC: PMC9198908. DOI:10.1182/bloodadvances.2021005847.
(en) Zu, Yingling, Li, Zhen, Gui, Ruirui, Liu, Yanyan, Zhang, Yanli (2022-10). Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial. Gearchiveerd op 1 juni 2023. Bone Marrow Transplantation 57 (10): 1573–1580. ISSN:0268-3369. PMID: 35840747. PMC: PMC9532243. DOI:10.1038/s41409-022-01754-y.
(en) Fisher, Sheila A, Cutler, Antony, Doree, Carolyn, Brunskill, Susan J, Stanworth, Simon J (30 januari 2019). Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database of Systematic Reviews 2019 (1). PMID: 30697701. PMC: PMC6353308. DOI:10.1002/14651858.CD009768.pub2.

nature.com

(en) Zu, Yingling, Li, Zhen, Gui, Ruirui, Liu, Yanyan, Zhang, Yanli (2022-10). Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial. Gearchiveerd op 1 juni 2023. Bone Marrow Transplantation 57 (10): 1573–1580. ISSN:0268-3369. PMID: 35840747. PMC: PMC9532243. DOI:10.1038/s41409-022-01754-y.

nih.gov

ncbi.nlm.nih.gov

Bijvoorbeeld Kohler S, Pascher A, et al. Graft versus host disease after liver transplantation - a single center experience and review of literature. Transpl Int. 2008 May;21(5):441-51. PMID 18266778
Bijvoorbeeld Ohtsuka Y, Sakemi T, et al. A case of chronic graft-versus-host disease following living-related donor kidney transplantation. Nephron. 1998;78(2):215-7. PMID 9496741
(en) Broers, Annoek E. C., de Jong, Cornelis N., Bakunina, Katerina, Hazenberg, Mette D., van Marwijk Kooy, Marinus (14 juni 2022). Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial. Gearchiveerd op 1 juni 2023. Blood Advances 6 (11): 3378–3385. ISSN:2473-9529. PMID: 35143644. PMC: PMC9198908. DOI:10.1182/bloodadvances.2021005847.
(en) Zu, Yingling, Li, Zhen, Gui, Ruirui, Liu, Yanyan, Zhang, Yanli (2022-10). Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial. Gearchiveerd op 1 juni 2023. Bone Marrow Transplantation 57 (10): 1573–1580. ISSN:0268-3369. PMID: 35840747. PMC: PMC9532243. DOI:10.1038/s41409-022-01754-y.
(en) Fisher, Sheila A, Cutler, Antony, Doree, Carolyn, Brunskill, Susan J, Stanworth, Simon J (30 januari 2019). Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database of Systematic Reviews 2019 (1). PMID: 30697701. PMC: PMC6353308. DOI:10.1002/14651858.CD009768.pub2.

web.archive.org

(en) Broers, Annoek E. C., de Jong, Cornelis N., Bakunina, Katerina, Hazenberg, Mette D., van Marwijk Kooy, Marinus (14 juni 2022). Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial. Gearchiveerd op 1 juni 2023. Blood Advances 6 (11): 3378–3385. ISSN:2473-9529. PMID: 35143644. PMC: PMC9198908. DOI:10.1182/bloodadvances.2021005847.
(en) Zu, Yingling, Li, Zhen, Gui, Ruirui, Liu, Yanyan, Zhang, Yanli (2022-10). Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial. Gearchiveerd op 1 juni 2023. Bone Marrow Transplantation 57 (10): 1573–1580. ISSN:0268-3369. PMID: 35840747. PMC: PMC9532243. DOI:10.1038/s41409-022-01754-y.

wiley.com

doi.wiley.com

(en) Fisher, Sheila A, Cutler, Antony, Doree, Carolyn, Brunskill, Susan J, Stanworth, Simon J (30 januari 2019). Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database of Systematic Reviews 2019 (1). PMID: 30697701. PMC: PMC6353308. DOI:10.1002/14651858.CD009768.pub2.

worldcat.org

(en) Broers, Annoek E. C., de Jong, Cornelis N., Bakunina, Katerina, Hazenberg, Mette D., van Marwijk Kooy, Marinus (14 juni 2022). Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial. Gearchiveerd op 1 juni 2023. Blood Advances 6 (11): 3378–3385. ISSN:2473-9529. PMID: 35143644. PMC: PMC9198908. DOI:10.1182/bloodadvances.2021005847.
(en) Zu, Yingling, Li, Zhen, Gui, Ruirui, Liu, Yanyan, Zhang, Yanli (2022-10). Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre, randomized controlled trial. Gearchiveerd op 1 juni 2023. Bone Marrow Transplantation 57 (10): 1573–1580. ISSN:0268-3369. PMID: 35840747. PMC: PMC9532243. DOI:10.1038/s41409-022-01754-y.